Efficacy of immune checkpoint inhibitors for in-transit melanoma.
Emilia Nan TieJulia Lai-KwonMichael Alexander RtshiladzeLumine NaJames BozziTavis ReadVictoria AtkinsonGeorge Au-YeungGeorgina V LongGrant A McArthurShahneen SandhuRobyn SawEuan WalpoleAlexander MenziesMark SmithersDavid E GyorkiPublished in: Journal for immunotherapy of cancer (2021)
ICI produce objective responses in ITM and should be considered in patients with unresectable ITM or disease recurrence.